Search results
Results From The WOW.Com Content Network
Chagas disease is caused by infection with the protozoan parasite T. cruzi, which is typically introduced into humans through the bite of triatomine bugs, also called "kissing bugs". [4] When the insect defecates at the bite site, motile T. cruzi forms called trypomastigotes enter the bloodstream and invade various host cells. [5]
Trypanosoma brucei rhodiense is usually found on the eastern side of the valley while the gambiense variant resides on the western side. [11] The ranges of the two disease variants could overlap in Uganda, Tanzania, and Congo in the future. [18] Trypanosomiasis case numbers reported to the WHO from 2000-2013.
The disease has spread to the U.S. in the last 40 years, says the American Heart Association, but many doctors are unfamiliar with how to diagnose and treat it.
The logo of the Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, [1] malaria, filarial ...
If you receive Social Security Disability Insurance (SSDI), you could qualify for additional government assistance, including the Supplemental Nutrition Assistance Program (SNAP). Food Stamps: 4...
SNAP, formerly known as food stamps, provides nutritional benefits for low-income households who meet program rules. In Texas, SNAP benefits are administered by the Texas Health and Human Services...
The date you receive your Texas SNAP food benefits is based on your Eligibility Determination Group (EDG) number, with benefits being deposited onto Lone Star Cards at different dates, depending ...
Given the 100 million people at risk and Chagas disease's disease burden, funding for R&D to improve treatments is extremely low, making it one of the most neglected of the neglected diseases. In 2007, less than US$1 million (0.04% of R&D funding dedicated to neglected diseases) was spent on the development of new drugs for Chagas disease. [7] [8]